Literature DB >> 14526128

CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.

Andrea L Ferreira Bernardino1, Dulce Reis Guarita, Carlos Barros Mott, Martha Regina Arcon Pedroso, Marcel Cerqueira Cesar Machado, Antonio Atilio Laudanna, Claudia Megume Tani, Fatima Lovatti Almeida, Mayana Zatz.   

Abstract

CONTEXT: Mutations in cystic fibrosis transmembrane conductance regulator (CFTR), in cationic trypsinogen (PRSS1) and in serine protease inhibitor Kazal type 1 (SPINK1) genes have been associated with chronic pancreatitis (alcohol related, idiopathic and hereditary). However, the inheritance pattern is still not clear. PATIENTS: Eighty-two unrelated Brazilian patients with chronic pancreatitis (alcohol-related disease in 64, idiopathic disease in 16, and hereditary disease in 2). Two hundred unrelated individuals with an ethnic distribution comparable to the patients were studied as controls. MAIN OUTCOME MEASURE: Detection of mutations in CFTR, PRSS1, and SPINK1 genes.
RESULTS: Mutations in the CFTR gene were found in 8 patients (9.8%) with chronic pancreatitis, 5 of them with idiopathic disease. Interestingly, the only clinical symptom in a male patient in the alcoholic group, who was a compound heterozygote (DeltaF508/R170C) for two CFTR mutations, was pancreatitis without infertility or pulmonary involvement. In the PRSS1 gene, the E79K change in exon 3 was found in one patient (1.2%) with alcohol-related chronic pancreatitis. Four different alterations were identified in the SPINK1 gene.
CONCLUSIONS: Mutations in the CFTR gene represent the major cause of idiopathic chronic pancreatitis in Brazilian patients. No mutation was found in the PRSS1 gene among our patients suggesting further genetic heterogeneity for hereditary and idiopathic chronic pancreatitis. Interestingly, the most frequent SPINK1 N34S mutation was not present in patients or controls. Moreover, the -253C allele for the SPINK1 gene was significantly more frequent in patients than controls (P=0.004), suggesting that it might represent a risk factor for the development of pancreatitis in our population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526128

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  17 in total

Review 1.  Where there's smoke there's not necessarily fire.

Authors:  M V Apte; R C Pirola; J S Wilson
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 2.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

Review 3.  Diagnostic approach to patients with acute idiopathic and recurrent pancreatitis, what should be done?

Authors:  Mohammad Al-Haddad; Michael B Wallace
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 4.  Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.

Authors:  Balázs Csaba Németh; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-23       Impact factor: 4.052

5.  Pancreatic secretory trypsin inhibitor: More than a trypsin inhibitor.

Authors:  Gai-Ping Wang; Cun-Shuan Xu
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

6.  Functional significance of SPINK1 promoter variants in chronic pancreatitis.

Authors:  Monique H M Derikx; Andrea Geisz; Éva Kereszturi; Miklós Sahin-Tóth
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-19       Impact factor: 4.052

7.  Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls.

Authors:  F U Weiss; P Simon; N Bogdanova; J Mayerle; B Dworniczak; J Horst; M M Lerch
Journal:  Gut       Date:  2005-06-29       Impact factor: 23.059

8.  Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2).

Authors:  David C Whitcomb; Dhiraj Yadav; Slivka Adam; Robert H Hawes; Randall E Brand; Michelle A Anderson; Mary E Money; Peter A Banks; Michele D Bishop; John Baillie; Stuart Sherman; James DiSario; Frank R Burton; Timothy B Gardner; Stephen T Amann; Andres Gelrud; Simon K Lo; Mark T DeMeo; William M Steinberg; Michael L Kochman; Babak Etemad; Christopher E Forsmark; Beth Elinoff; Julia B Greer; Michael O'Connell; Janette Lamb; M Michael Barmada
Journal:  Pancreatology       Date:  2008-09-03       Impact factor: 3.996

9.  CFTR gene mutations in pancreatitis: Frequency and clinical manifestations in an Austrian patient cohort.

Authors:  Heinz Zoller; Margit Egg; Ivo Graziadei; Marc Creus; Andreas R Janecke; Judith Löffler-Ragg; Wolfgang Vogel
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

10.  PRSS1 and SPINK1 mutations in idiopathic chronic and recurrent acute pancreatitis.

Authors:  Mario Pelaez-Luna; Guillermo Robles-Diaz; Samuel Canizales-Quinteros; Maria T Tusié-Luna
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.